FDA panel recommends deflating heart balloon pumps risk category; but Abiomed's Impella likely faces stricter regs
06 December 2012
- FDA questions Bard's data in advance of panel for Lutonix drug-coated balloon
- MARKET INSIGHT: VADs the way - heart assist devices to show biggest procedure volume growth in EU
- Total recall: October jump signals year-end rise?
- ANALYSIS: Boston scores six April approvals as cardiology and imaging dominate
Other Informa News